Sambaturu Narmada, Fray Emily J, Wu Fengting, Zitzmann Carolin, Simonetti Francesco R, Barouch Dan H, Siliciano Janet D, Siliciano Robert F, Ribeiro Ruy M, Perelson Alan S, Molina-París Carmen, Leitner Thomas
Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
bioRxiv. 2023 Nov 3:2023.11.03.565539. doi: 10.1101/2023.11.03.565539.
HIV can persist in a latent form as integrated DNA (provirus) in resting CD4 T cells of infected individuals and as such is unaffected by antiretroviral therapy (ART). Despite being a major obstacle for eradication efforts, the genetic variation and timing of formation of this latent reservoir remains poorly understood. Previous studies on when virus is deposited in the latent reservoir have come to contradictory conclusions. To reexamine the genetic variation of HIV in CD4 T cells during ART, we determined the divergence in envelope sequences collected from 10 SIV infected rhesus macaques. We found that the macaques displayed a biphasic decline of the viral divergence over time, where the first phase lasted for an average of 11.6 weeks (range 4-28 weeks). Motivated by recent observations that the HIV-infected CD4 T cell population is composed of short- and long-lived subsets, we developed a model to study the divergence dynamics. We found that SIV in short-lived cells was on average more diverged, while long-lived cells harbored less diverged virus. This suggests that the long-lived cells harbor virus deposited starting earlier in infection and continuing throughout infection, while short-lived cells predominantly harbor more recent virus. As these cell populations decayed, the overall proviral divergence decline matched that observed in the empirical data. This model explains previous seemingly contradictory results on the timing of virus deposition into the latent reservoir, and should provide guidance for future eradication efforts.
人类免疫缺陷病毒(HIV)可以以整合DNA(前病毒)的潜伏形式存在于受感染个体的静息CD4 T细胞中,因此不受抗逆转录病毒疗法(ART)的影响。尽管这是根除努力的一个主要障碍,但这种潜伏库的基因变异和形成时间仍知之甚少。先前关于病毒何时沉积在潜伏库中的研究得出了相互矛盾的结论。为了重新审视抗逆转录病毒疗法期间CD4 T细胞中HIV的基因变异,我们确定了从10只感染猴免疫缺陷病毒(SIV)的恒河猴收集的包膜序列的差异。我们发现,随着时间的推移,恒河猴的病毒差异呈现双相下降,其中第一阶段平均持续11.6周(范围为4 - 28周)。受最近观察结果的启发,即受HIV感染的CD4 T细胞群体由短期和长期存活的亚群组成,我们开发了一个模型来研究差异动态。我们发现,短期存活细胞中的SIV平均差异更大,而长期存活细胞中携带的病毒差异较小。这表明,长期存活细胞中携带的病毒在感染早期就开始沉积,并在整个感染过程中持续存在,而短期存活细胞主要携带较新的病毒。随着这些细胞群体的衰减,总体前病毒差异下降与经验数据中观察到的情况相匹配。该模型解释了先前关于病毒沉积到潜伏库时间的看似矛盾的结果,并应为未来的根除努力提供指导。